Clinical Trial Update: Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing radiofrequency ablation with transcatheter arterial chemoembolization versus radiofrequency ablation alone for recurrent hepato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, RFA | Phase 4 | Status: UNKNOWN